Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

R Pofi, G Caratti, DW Ray, JW Tomlinson - Endocrine Reviews, 2023 - academic.oup.com
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

The mammalian circadian time-kee** system

AP Patton, MH Hastings - Journal of Huntington's disease, 2023 - journals.sagepub.com
Our physiology and behavior follow precise daily programs that adapt us to the alternating
opportunities and challenges of day and night. Under experimental isolation, these rhythms …

An atlas of regulatory elements in chicken: A resource for chicken genetics and genomics

Z Pan, Y Wang, M Wang, Y Wang, X Zhu, S Gu… - Science …, 2023 - science.org
A comprehensive characterization of regulatory elements in the chicken genome across
tissues will have substantial impacts on both fundamental and applied research. Here, we …

Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application

Y Chen, R Liang, Y Li, L Jiang, D Ma, Q Luo… - Signal Transduction and …, 2024 - nature.com
The dynamic regulation of chromatin accessibility is one of the prominent characteristics of
eukaryotic genome. The inaccessible regions are mainly located in heterochromatin, which …

Nuclear receptor corepressors non-canonically drive glucocorticoid receptor-dependent activation of hepatic gluconeogenesis

AK Hauck, R Mehmood, BJ Carpenter… - Nature …, 2024 - nature.com
Nuclear receptor corepressors (NCoRs) function in multiprotein complexes containing
histone deacetylase 3 (HDAC3) to alter transcriptional output primarily through repressive …

A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death

C Van Dender, S Timmermans… - EMBO Molecular …, 2024 - embopress.org
In sepsis, limited food intake and increased energy expenditure induce a starvation
response, which is compromised by a quick decline in the expression of hepatic PPARα, a …

Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease

MB Antwi, A Jennings, S Lefere, D Clarisse… - npj Metabolic Health …, 2024 - nature.com
Nuclear receptors (NRs) regulate cellular processes and serve as key targets in treating
metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis …

The role of hepatocyte nuclear factor 4α (HNF4α) in tumorigenesis

L Sang, X Wang, W Bai, J Shen, Y Zeng… - Frontiers in Oncology, 2022 - frontiersin.org
Hepatocyte Nuclear Factor 4 Alpha (HNF4α) is a master transcription factor mainly
expressed in the liver, kidney, intestine and endocrine pancreas. It regulates multiple target …

EJE Prize 2023: genes on steroids—genomic control of hepatic metabolism by the glucocorticoid receptor

F Quagliarini, K Makris, ME Friano… - European Journal of …, 2023 - academic.oup.com
Glucocorticoids are essential hormones produced by the adrenal cortex with prominent
circadian rhythmicity and in times of stress. Glucocorticoids maintain liver homeostasis …

HNF4A guides the MLL4 complex to establish and maintain H3K4me1 at gene regulatory elements

A Thakur, K Park, R Cullum, BM Fuglerud… - Communications …, 2024 - nature.com
Hepatocyte nuclear factor 4A (HNF4A/NR2a1), a transcriptional regulator of hepatocyte
identity, controls genes that are crucial for liver functions, primarily through binding to …